Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CASP5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | FBLN7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | CD300LF | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | IPP | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | PIK3C2B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | GFPT1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | COG3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | IGSF9 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | IRGC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |